FDA reports Johnson & Johnson vaccine raises risk of rare nerve syndrome

Johnson & Johnson‘s coronavirus vaccine has suffered yet another setback with the Food and Drug Administration reporting that receiving the vaccine can lead to an increased risk of developing a rare neurological condition known as Guillain-Barré syndrome. While the chance of developing the syndrome is low, receivers of the Johnson & Johnson vaccine are 3 […]

Pages: 1 2